PL353453A1 - Pochodne ascidideminy i ich terapeutyczne zastosowania - Google Patents

Pochodne ascidideminy i ich terapeutyczne zastosowania

Info

Publication number
PL353453A1
PL353453A1 PL00353453A PL35345300A PL353453A1 PL 353453 A1 PL353453 A1 PL 353453A1 PL 00353453 A PL00353453 A PL 00353453A PL 35345300 A PL35345300 A PL 35345300A PL 353453 A1 PL353453 A1 PL 353453A1
Authority
PL
Poland
Prior art keywords
ascididemin
derivatives
therapeutic applications
compounds
antitumoral
Prior art date
Application number
PL00353453A
Other languages
English (en)
Inventor
Evelyne Delfourne
Francis Darro
Jean Bastide
Robert Kiss
Armand Frydmann
Original Assignee
Laboratoire L.Lafon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9910490A external-priority patent/FR2797445B1/fr
Priority claimed from FR0006652A external-priority patent/FR2809399B1/fr
Application filed by Laboratoire L.Lafon filed Critical Laboratoire L.Lafon
Publication of PL353453A1 publication Critical patent/PL353453A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16—Peri-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL00353453A 1999-08-13 2000-08-11 Pochodne ascidideminy i ich terapeutyczne zastosowania PL353453A1 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9910490A FR2797445B1 (fr) 1999-08-13 1999-08-13 Derives d'ascididemine et leurs applications therapeutiques
FR0006652A FR2809399B1 (fr) 2000-05-24 2000-05-24 Nouveaux derives d'ascididemine et leurs applications therapeutiques
PCT/FR2000/002312 WO2001012631A2 (fr) 1999-08-13 2000-08-11 Derives d'ascididemine et leurs applications therapeutiques

Publications (1)

Publication Number Publication Date
PL353453A1 true PL353453A1 (pl) 2003-11-17

Family

ID=26212422

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00353453A PL353453A1 (pl) 1999-08-13 2000-08-11 Pochodne ascidideminy i ich terapeutyczne zastosowania

Country Status (20)

Country Link
EP (1) EP1202992B1 (pl)
JP (1) JP2003507381A (pl)
CN (1) CN1195754C (pl)
AT (1) ATE276256T1 (pl)
AU (1) AU779932B2 (pl)
BR (1) BR0013249A (pl)
CA (1) CA2393965A1 (pl)
CZ (1) CZ2002528A3 (pl)
DE (1) DE60013849T2 (pl)
DK (1) DK1202992T3 (pl)
ES (1) ES2228602T3 (pl)
HU (1) HUP0202767A3 (pl)
IL (1) IL147900A0 (pl)
MX (1) MXPA02001512A (pl)
NO (1) NO20020668L (pl)
NZ (1) NZ516896A (pl)
PL (1) PL353453A1 (pl)
PT (1) PT1202992E (pl)
SK (1) SK1662002A3 (pl)
WO (1) WO2001012631A2 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018104194A1 (de) * 2016-12-05 2018-06-14 Merck Patent Gmbh Materialien für organische elektrolumineszenzvorrichtungen

Also Published As

Publication number Publication date
ES2228602T3 (es) 2005-04-16
MXPA02001512A (es) 2002-07-02
EP1202992A2 (fr) 2002-05-08
NO20020668D0 (no) 2002-02-11
HUP0202767A2 (hu) 2003-01-28
NO20020668L (no) 2002-04-15
IL147900A0 (en) 2002-08-14
CN1195754C (zh) 2005-04-06
SK1662002A3 (en) 2002-09-10
CA2393965A1 (fr) 2001-02-22
DK1202992T3 (da) 2005-01-24
JP2003507381A (ja) 2003-02-25
AU779932B2 (en) 2005-02-17
BR0013249A (pt) 2002-04-16
CZ2002528A3 (cs) 2002-05-15
WO2001012631A2 (fr) 2001-02-22
DE60013849D1 (de) 2004-10-21
ATE276256T1 (de) 2004-10-15
CN1373762A (zh) 2002-10-09
EP1202992B1 (fr) 2004-09-15
HUP0202767A3 (en) 2003-12-29
DE60013849T2 (de) 2005-02-03
WO2001012631A3 (fr) 2001-07-19
PT1202992E (pt) 2004-12-31
AU7012400A (en) 2001-03-13
NZ516896A (en) 2004-02-27

Similar Documents

Publication Publication Date Title
AP9801169A0 (en) N-hydroxy-B-sulfonyl propionamide derivatives.
GEP20063799B (en) Tropane derivatives useful in therapy
GEP20032896B (en) 4-Aminothiazole Derivatives, Containing Them Pharmaceutical Compositions Inhibiting Cyclin-Dependent Kinases and Methods for Treatment
ATE312080T1 (de) 2-chinolonen enthaltende arzneimittel
GEP20043241B (en) Compounds for Treatment of Ischemia and Pharmaceutical Compositions Containing the Same
GEP20033001B (en) Alkynyl-Substituted Quinolin-2-One Derivatives Useful As Anticancer Agents
GEP20053454B (en) Aryl Fused Azapolycyclic Compounds, Composition Containing the Same and Use Thereof
GEP20032999B (en) 1-Heterocycle Substituted Diarylamines
YU57600A (sh) Derivarti biciklične hidroksaminske kiseline
MY127126A (en) Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
GEP20084329B (en) 5,7-diaminopyrazolo [4,3-d] pyrimidines useful in the treatment of hypertension
AP2002002578A0 (en) Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses.
MXPA02012034A (es) Derivados de tiofeno utiles como agentes anticancerosos.
BG103947A (en) Derivatives of 9-oxymerythromycin
GEP20043250B (en) Use of Indolyl-3-Glyoxylic Acid Derivatives as Anti-tumor Means and Pharmaceutical Compositions Containing the Same
MY133112A (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
BG105570A (en) Pharmaceutical compositions for modified release insulin sensitiser
YU59400A (sh) Azabiciklični ligandi 5ht1 receptora
AP9801377A0 (en) Tricyclic erythromycin derivatives.
GEP20043227B (en) 5HT1 Antagonists for Antidepressant Therapy
GEP20043225B (en) 1-Trifluoromethyl-4-Hydroxy-7- Piperidinyl-Aminomethylchroman Derivatives
WO2001012632A3 (fr) Derives de phenanthroline-7-ones et leurs applications en therapeutique
IL147900A0 (en) Ascididemin derivatives and their therapeutic applications
WO2001012607A3 (fr) Compositions pharmaceutiques comprenant des 4-quinolones pour le traitement des cancers
YU46302A (sh) Supstituisani piroli

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)